RAP-103
RAP-103 is an orally active CCR antagonist that effectively protects synapses by inhibiting and reversing cytoskeletal changes induced by PrPC/NOX signaling. RAP-103 is applicable for research in Alzheimer's disease (AD) .
Product Specifications
Molecular Weight
598.61
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15387734 1 Vial
Lentiviral human LPIN2 sgRNA gene knockout kit - Lentiviral human LPIN2 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 
69194111 3x 1.0 µg
ZNF487 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details sc-290975 100 mg
5-Phenyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester
Sign In for Pricing
View Details